跳至主要内容
临床试验/NCT05238077
NCT05238077终止不适用

Comparing the Efficacy of VL-UVA1 Versus NB-UVB on Inducing Repigmentation in Subjects With Generalized Vitiligo

Henry Ford Health System2 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2018年2月26日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
1
试验地点
2
主要终点
Change in melanin content of vitiligo lesion

研究概览

简要总结

As part of this study, you may have a procedure called phototherapy which involves either VL-UVA or NB-UVB irradiation. NB-UVB phototherapy is not experimental in vitiligo, but use of VL-UVA1 phototherapy in vitiligo is.

The purpose of this pilot study is to determine whether VL-UVA1 or NB-UVB phototherapy more efficiently induces repigmentation in patients with generalized vitiligo.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects ≥ 18 years of age with a diagnosis of generalized vitiligo
  • Subjects on a stable topical/oral regimen for the past 3 months and continuing on a stable regimen
  • Subjects able to understand the requirements of the study
  • Subjects able and willing to sign informed consent

排除标准

  • Subjects on photosensitizing medications
  • Subjects receiving any concurrent phototherapy
  • Subjects who plan to use tanning parlors or expose themselves to excess sunlight
  • Subjects with known photosensitivity disorder
  • Subjects with apparent phototoxicity
  • Subjects with unstable vitiligo
  • Subjects currently using bleaching agents
  • Subjects who are pregnant, lactating, or planning on becoming pregnant
  • Subjects who in the opinion of the investigator/sub-investigator, are not appropriate candidates for this study

结局指标

主要结局

Change in melanin content of vitiligo lesion

时间窗: 13 measurements over 26 visits

Change in pigment will be assessed by diffuse reflectance spectroscopy which will measure the melanin content and dyschromia

Change in depigmentation of vitiligo lesion

时间窗: 13 measurements over 26 visits

Change in pigment will be assessed by colorimetry which measures change in pigment

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Iltefat Hamzavi

Director Investigator Initiated Studies

Henry Ford Health System

研究点 (2)

Loading locations...

相似试验